Autoinflammatory & rare systemic diseases

Immunohistochemical expression of DnaJ homolog subfamily B member 9 in immunoglobulin G4-related disease: a pilot study

Clin Exp RheumatolPublished Pilot immunohistochemical study

Authors' conclusion

Our findings evidenced reduced immunohistochemical expression of DNAJB9 in IgG4-RD endothelial cells, and suggested loss of expression in other cell types, possibly correlating with disease severity and risk of relapse.

Study context

Population
Tissue slides of patients with definite immunoglobulin G4-related disease (IgG4-RD) and normal tissue controls, including salivary gland, pancreatic, pulmonary, pleural, and retroperitoneal fibrosis tissue
Participants
9 vs 15
Comparison
IgG4-RD tissue specimens vs normal tissue controls
  • IgG4-RDn = 9
  • Controlsn = 15reference
Outcome
Immunohistochemical distribution and intensity of DNAJB9 (semi-quantitative staining intensity score)
Methodological detailssemi-quantitative staining intensity score
  • Semi-quantitative staining intensity score

Main finding

As reported in the abstract

DNAJB9 immunohistochemical intensity, endothelial cells

ES

1.58

P < 0.01

By group

IgG4-RD

0

Median

Controls

2

Median

Further findings

Median

OutcomeIgG4-RDControlsESP value
DNAJB9 immunohistochemical intensity, glandular epithelial cells2— not stated in the abstract0.70P = 0.26
DNAJB9 immunohistochemical intensity, inflammatory cells (salivary glands alone)230.90P = 0.11

— not stated in the abstract

Correlation of endothelial staining intensity with serum IgG4 concentrations and number of treatments to achieve remission

Correlation with serum IgG4 concentrations (r), p=0.03
−0.72
Correlation with number of treatments required to achieve remission (r), p=0.04
−0.70

Original publication

Immunohistochemical expression of DnaJ homolog subfamily B member 9 in immunoglobulin G4-related disease: a pilot study. Clin Exp Rheumatol. Published 29 June 2023. doi:10.55563/clinexprheumatol/mycifa

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.